Hypothesis

Acute, programmed senescence in endometrial stromal Str4 cells forms reversible, chaperone-enriched liquid-liquid phase-separated condensates that concentrate SASP effectors (MMP11, ADAM12, WNT ligands) and enable dynamic ECM remodeling for implantation. In contrast, premature or stress-induced senescence bypasses this condensate checkpoint, leading to disordered, ubiquitin‑tagged aggregates that disrupt FOXO1 signaling and poison neighboring cells. The protective versus destructive outcome depends on whether aggregation is harnessed by the HSPB1‑DNAJB6‑HSP70 axis into a liquid‑like depot or allowed to mature into irreversible amyloid‑like deposits.

Mechanistic Rationale

1. Condensate nucleation via HSPB1‑DNAJB6 – HSPB1 (Hsp27) and its co‑chaperone DNAJB6 are known to suppress amyloid formation by promoting soluble oligomers. In decidualizing stromal cells, progesterone‑induced FOXO1 upregulates HSPB1 and DNAJB6, creating a microenvironment where nascent SASP proteins are sequestered into dynamic droplets rather than allowed to fibrillize.
2. Liquid‑like properties enable rapid exchange – Fluorescence recovery after photobleaching (FRAP) of HSPB1‑SASP fusions would show high mobile fractions, consistent with a liquid depot that can be disassembled by hormonal withdrawal or embryo‑derived signals.
3. Ubiquitin tagging as a failure mode – When HSPB1/DNAJB6 are depleted or overwhelmed (e.g., by oxidative stress in aging), misfolded SASP precursors accumulate ubiquitin chains, are recognized by p62/SQSTM1, and nucleate insoluble aggregates that activate NF‑κB in a paracrine fashion, explaining the observed SASP‑mediated toxicity in premature senescence.
4. CDC42 links cytoskeletal tension to condensate stability – CDC42 governs actin polarity; its loss disrupts the mechanical anchorage of condensates to the perinuclear region, causing dispersal and subsequent aggregation, aligning with the CDC42 deficiency phenotype.
5. Reversibility explains the “dynamic implantation environment” – The ability to dissolve condensates upon embryo attachment provides a timed release of ECM‑remodeling factors, whereas irreversible aggregates persist, leading to a static, hostile stroma.

Testable Predictions

• Prediction 1: In vitro decidualization of human endometrial stromal cells (hESCs) will show HSPB1‑DNAJB6 co‑localization with MMP11 and ADAM12 in puncta that are sensitive to 1,6‑hexanediol (an LLPS disruptor) but resistant to sucrose gradient sedimentation indicative of amyloid.
• Prediction 2: Knockdown of HSPB1 or DNAJB6 will shift SASP protein distribution from soluble condensates to ubiquitin‑positive, thioflavin‑T‑negative aggregates, reduce PRL/IGFBP1 secretion, and impair embryo outgrowth in assembloid assays.
• Prediction 3: Treatment of aged hESCs with a young uterotrophic serum (or conditioned serum from young mice) will restore HSPB1/DNAJB6 expression, increase condensate formation, and rescue decidualization metrics without altering global proteasome activity.
• Prediction 4: Proteomic isolation of condensates (via differential solubility fractionation) from Str4‑like cells will enrich for SASP components, chaperones, and RNA‑binding proteins, whereas aggregates from senescent‑failed cells will be enriched for ubiquitinated histones, p62, and insoluble collagen fragments.

Falsifiability

If HSPB1/DNAJB6 knockdown does not increase ubiquitin‑tagged SASP aggregates or if hexanediol treatment fails to disrupt SASP puncta without affecting overall secretion, the condensate‑centric model is invalid. Likewise, if young uterine serum restores decidualization without rescuing HSPB1/DNAJB6 levels or condensate formation, the proposed upstream mechanism is insufficient.

Significance

Reframing aggregation as a regulated, reversible depot shifts the therapeutic focus from global proteostasis enhancement to modulating specific chaperone‑LLPS axes. This could explain why broad anti‑aggregation strategies have failed in reproductive aging and offers a precise target: bolster HSPB1‑DNAJB6‑mediated condensogenesis to convert pathological senescence back into its implantation‑supportive form.